Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership122,768 shares
Latest Disclosed Value $ 7,445,900
Belpointe Asset Management LLC reports 2.62% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 122,768 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $6,435,499 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 119,636 shares of Bristol-Myers Squibb Company. This represents a change in shares of 2.62% during the quarter. The current value of the position is $5,822,886 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 122,768 3,132 2.62 7,446 15.37 0.2718
2026-01-27 2025-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 119,636 16,388 15.87 6,453 38.60 0.2331
2025-11-03 2025-09-30 13F Bristol-Myers Squibb COM 110122108 103,248 30,833 42.58 4,657 38.90 0.1779
2025-07-22 2025-06-30 13F Bristol-Myers Squibb COM 110122108 72,415 -24,163 -25.02 3,352 -43.09 0.1397
2025-05-20 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 96,578 -91,863 -48.75 5,890 -37.42 0.3065
2025-02-13 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 188,441 -6,943 -3.55 9,413 -6.89 0.5670
2024-11-13 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 195,384 5,955 3.14 10,109 28.50 0.6064
2024-08-02 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 189,429 6,004 3.27 7,867 -20.91 0.5487
2024-05-08 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 183,425 24,803 15.64 9,947 22.23 0.7450
2024-02-13 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 158,622 -3,335 -2.06 8,139 -13.42 0.7148
2023-11-15 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 161,957 -267 -0.16 9,400 -9.40 0.9735
2023-08-15 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 162,224 6,906 4.45 10,374 -3.63 1.0974
2023-05-15 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 155,318 5,030 3.35 10,765 -0.44 0.5814
2023-02-08 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 150,288 956 0.64 10,813 1.86 0.6534
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 149,332 2,290 1.56 10,616 -6.23 0.7175
2022-08-02 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 147,042 -19,607 -11.77 11,321 -6.98 0.7589
2022-04-28 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 166,649 10,519 6.74 12,171 25.02 0.7376
2022-02-15 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 156,130 -1,325 -0.84 9,735 4.49 0.6068
2021-11-15 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 157,455 3,232 2.10 9,317 -9.60 0.6352
2021-08-09 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 154,223 -88,637 -36.50 10,306 -32.78 0.7417
2021-05-14 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 242,860 31,593 14.95 15,332 16.99 1.3125
2021-02-16 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 211,267 18,133 9.39 13,105 12.56 1.1762
2020-11-13 2020-09-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 193,134 1,439 0.75 11,643 3.29 1.2958
2020-11-13 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 189,128 10,543
2020-07-20 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 191,695 2,567 1.36 11,272 6.91 1.4594
2020-07-20 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 189,128 15,814 9.12 10,543 -5.22 1.8465
2020-02-18 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 173,314 11,325 6.99 11,124 35.43 1.4116
2020-01-16 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 161,989 -423 -0.26 8,214 11.53 1.3286
2019-11-22 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 162,412 -4,614 -2.76 7,365 -7.58 1.4487
2019-06-11 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 167,026 -147 -0.09 7,969 -8.30 1.5565
2019-03-06 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 167,173 -4,425 -2.58 8,690 -18.43 2.2024
2018-11-23 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 171,598 11,766 7.36 10,653 20.44 1.6848
2018-08-06 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 159,832 538 0.34 8,845 -12.21 2.4711
2018-08-06 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 159,294 -3,438 -2.11 10,075 1.03 2.9367
2018-02-14 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 162,732 -1,154 -0.70 9,972 -4.54 2.1844
2017-11-16 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 163,886 163,886 10,446 2.4438
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.